Virupaksha stands at the forefront of pharmaceutical manufacturing, delivering excellence with a commitment to quality and innovation that resonates through every aspect of its operations. Specializing in high-purity Fluconazole, the company aligns its production processes with stringent WHO-GMP standards, ensuring that each batch meets international safety and efficacy benchmarks vital for treating conditions like cryptococcal meningitis.
The dedication to quality is further underscored by their ISO 9001 certification, which guarantees robust management practices focused on continual improvement and customer satisfaction. Additionally, Virupaksha’s adherence to ISO 14001 reflects their unwavering responsibility towards environmental sustainability;
they strive not only for therapeutic advancements but also for eco-friendly solutions that contribute positively to global health outcomes. As a result, healthcare providers can trust in Virupaksha’s products as they navigate the complexities of treatment options available today.
Other Latest News
- Dr Reddy’s layoffs: Pharma major to cut workforce cost by 25%? Here's what the drugmaker says April 14, 2025 1:31 pm Mint Dr Reddy's layoffs: Dr Reddy's Laboratories has categorically denied media reports claiming that the leading pharmaceutical major will likely cut its workforce costs by nearly 25 per cent as it begins a significant downsizing initiative. In a …
- US-China trade war: How India can turn crisis into opportunity April 13, 2025 8:08 am Firstpost The White House clarified that the levies on Chinese imports stand at 145 per cent—the 125 per cent tariff announced by President Donald Trump is in addition to the two hikes of 10 per cent post-Trump taking office. China’s unflinching approach has made …
- India's Pharma Industry Is Not Immune To The Spread Of AI March 25, 2025 11:18 pm Worldcrunch -Analysis- NEW DELHI — With nearly one-fifth of the global supply chain and 60% of the worldwide vaccine supply, the Indian pharmaceutical industry is a dominant global player. India has the highest number of U.S. Food and Drug Administration-approved …
- Delhi HC allows Natco to make Swiss pharma’s SMA drug in public interest March 25, 2025 4:15 pm The Indian Express In what could be promising news for patients battling spinal muscular atrophy (SMA), the Delhi High Court has refused to allow a suit by Swiss pharma giant Roche seeking to restrain Indian drugmaker Natco Pharma Ltd against manufacturing the drug Risdiplam …
- Trump tariffs drive pharma manufacturing to US but risk inflation and disruption March 25, 2025 11:59 am Pharmaceutical Technology The pharma industry has been left reeling by the recent news of US government trade tariffs, with companies Eli Lilly (Indianapolis, IN, US), Pfizer (New York, NY, US) and Merck & Co (Kenilworth, NJ, US) boosting their US manufacturing presence to …
- Alembic Pharmaceuticals completes USFDA inspection at Karakhadi API-III facility with zero observations March 22, 2025 4:55 am Business Upturn Alembic Pharmaceuticals Limited has successfully concluded a scheduled inspection by the United States Food and Drug Administration (USFDA) at its API-III manufacturing facility located in Karakhadi, Gujarat. The Good Manufacturing Practices (GMP) …
- Comparing an Inspection by a Regulator to an Investigation by a Pharma Company March 21, 2025 11:14 pm American Pharmaceutical Review Introduction Recently, there has been an increased focus on contamination control activities for pharmaceuticals due to updated requirements in the European Union’s Annex 1 Update. (EU, 2022). The recent update of Annex 1 (ISO 14644-1, 2022) has specified …
- DCAT Member Companies Present Latest News to Start DCAT Week 2025 March 17, 2025 8:17 pm Pharmaceutical Technology Twenty companies from all corners of the bio/pharmaceutical industry provided updates on their latest developments at the inaugural event of the Drug, Chemical & Associated Technologies Association (DCAT)’s annual gathering, DCAT Week, at the …
- Stocks in news: TCS, Wipro, Dalmia Bharat, Zydus Life, LIC Housing, Hindustan Zinc & IRFC March 6, 2025 2:53 am Business Today Indian benchmark indices snapped the 10-day losing streak to settle with decent gains on Wednesday on the back of weakness in the US Dollar leading to a relief rally. BSE Sensex jumped 740.30 points, or 1.01 per cent, to end at 73,730.23. NSE's Nifty50 …
- Stocks To Watch: From TCS to Wipro- Here’s a list of 10 stocks in news today March 6, 2025 2:26 am Financial Express Markets are always buzzing with action. Some of the biggest names in IT, finance, pharma, and infrastructure have announced key developments that could influence their stock performance. Whether it’s a new partnership, a major fundraising plan, or a …
- Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab February 28, 2025 4:19 pm Fierce Pharma Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. Pfizer has formed a clinical trial collaboration with Akeso's partner Summit Therapeutics. And …
- Pharma Pulse 2/28/25: Delivering Personalized Experiences at Scale, Combat Counterfeit Medications & more February 28, 2025 2:19 pm Pharmaceutical Commerce Delivering Personalized Experiences at Scale: A Fresh Look at Customer Centricity Customer centricity. An overused buzzword in the life sciences industry. Yet an important goal. In an era of eroding rep access, fragmented channels and growing complexity in …
- Stocks in news: Bharti Airtel, Dr Reddy’s, BEL, UltraTech, Adani Green, Tata Power & SpiceJet February 27, 2025 2:48 am Business Today Ahead of Wednesday's holiday, Indian benchmark indices settled on a mixed note on Tuesday due to muted global cues and key economic data later this week amid the dull sentiments over valuations and tariff concerns. BSE Sensex gained 147.71 points, or 0 …
- Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod February 21, 2025 4:06 pm Fierce Pharma Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing deal worth up to $1.3 billion. AstraZeneca is buying out its roxadustat partner FibroGen in China. Ono Pharmaceutical's $2.4 …
- Zealand Pharma Announces Financial Results for the Full Year 2024 February 20, 2025 6:00 am EIN Presswire Company announcement – No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity pipeline, while building the foundation for accelerated …
- Stocks in news: Waaree Energies, Cyient, Bharat Forge, IREDA, Tata Tech, Patanjali & RITES February 20, 2025 2:51 am Business Today Indian benchmark indices settled slightly lower on Wednesday amid mixed global and domestic cues. BSE Sensex shed 28.21 points, or 0.04 per cent, to end at 75,939.18. NSE's Nifty50 declined 12.40 points, or 0.05 per cent, to settle at 22,932.90. Here …
- Stocks To Watch: From Bharat Forge to Waaree Energies- Here’s a list of 10 stocks in news today February 20, 2025 1:41 am Financial Express Every trading day has its stars and strugglers. As the markets gear up for another trading session today, February 20, certain stocks are catching the spotlight. From major deals to policy shifts, here is a look at the stocks that are in focus. Market …
- Stocks to watch today: M&M, BHEL, Zydus Life, Alembic Pharma, and PCBL in focus on Feb 17, 2025 February 17, 2025 2:33 am Business Upturn Several stocks are in focus today based on key developments beyond Q3 earnings. M&M, BHEL, Zydus Life, Alembic Pharmaceuticals, and PCBL are among the notable companies making headlines. Key updates: M&M has set a new record in the electric vehicle …
- Stocks in news: Wipro, BHEL, Shriram Finance, ABB India, RVNL Glenmark Pharma & ABFRL February 17, 2025 2:19 am Business Today Indian benchmark indices continued to tumble for the eight straight session and ended in red on Friday on the back of weak Q3 earnings, consistent FII selling, trade tariffs tantrums in the US. BSE Sensex shed 199.76 points, or 0.26 per cent, to end at 75, …
- Stocks in news: HFCL, BHEL, Glenmark Pharma, ABFRL, Wipro February 17, 2025 1:10 am The Economic Times Equity markets remained volatile on Friday, shedding nearly half a percent amid mixed cues. In today's trade, shares of HFCL, BHEL, Glenmark Pharma, ABFRL, Wipro among others will be in focus due to various news developments. HFCL Domestic telecom gear …
- Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase' February 14, 2025 4:00 pm Fierce Pharma Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief strategy officer said. Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi " …
- Natco Pharma, Orchid Pharma, NBCC India, IPCA Labs: Stock price targets February 14, 2025 3:23 am Business Today Natco Pharma Ltd and Orchid Pharma Ltd are a couple of stocks that have plunged 15-20 per cent post their December quarter results, while stocks such as Ipca Laboratories Ltd (IPCA Labs) jumped on better-than-expected earnings. NBCC India, on the other …
- Natco Pharma Q3 Results: Check Company's Financial Earnings As Shares Fall February 13, 2025 8:49 am News18 Last Updated:February 13, 2025, 13:44 IST Natco Pharma Q3 Results: Its consolidated revenue from operations in October-December 2024 stands at Rs 474.8 crore as compared to Rs 758.6 crore in the same period a year ago. Natco Pharma Q3 Results: Formulation …
- IT, pharma are the sectors to watch as Modi meets Trump this week: Sunil Subramaniam February 11, 2025 3:39 am Covers Sunil Subramaniam, Market Expert, says Trumponomics is expected to benefit IT, while tariffs on Chinese APIs present an opportunity for rapid growth in pharmaceuticals. Both sectors can also gain from currency depreciation. However, Trumponomics won't …
- Business News | India's CDMO Market Set to Double by 2028 Amid Asia's Healthcare Boom February 9, 2025 9:23 am Latestly New Delhi [India], February 9 (ANI): India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to expand from USD 7 billion to USD 14 billion by 2028, capturing 4-5 per cent of the global …
- Aurobindo Pharma shares in focus after Q3 profit drops 10% YoY. Should you buy or sell? February 7, 2025 4:20 am Hoops Rumors Aurobindo Pharma shares will be in focus on Friday after the company reported a 10% year-on-year (YoY) decline in net profit to Rs 846 crore for the third quarter ended December 2023, impacted by weaker US sales despite strong growth in Europe, growth …
- Sun Pharma shares in focus after Q3 profit beats estimates; Nuvama raises target price February 1, 2025 3:20 am Zero Hedge Sun Pharma shares will be in focus on Saturday after the company reported a 15% year-on-year (YoY) increase in consolidated net profit to Rs 2,903 crore for the quarter ended December 2024. This includes an exceptional item of Rs 316 crore. The profit …
- Latest News | Fire Accident at Pharma Plant in Andhra January 21, 2025 4:44 am Latestly Anakapalli (Andhra Pradesh), Jan 21 (PTI) Fire broke out at a pharmaceutical company here on Tuesday morning and the flames were extinguished within 20 minutes, a police official said. None was injured in the accident, he added. Also Read | Kolkata Fatafat …
- INDIA API Market Gaining Ground at 8.50% CAGR to Reach 38.13 Billion USD by 2032 January 20, 2025 2:45 pm EIN Presswire INDIA API Market Insights: India remains a leading producer of APIs, with robust growth in domestic and export demand. US, NY, UNITED STATES, January 20, 2025 /EINPresswire.com/ -- Market Research Future Latest Industry Insights on “India API …
- Avicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin Pharma January 16, 2025 12:30 pm EIN Presswire TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based …